Artiria

Artiria has developed a micro-actuated device that allows treating vascular diseases with unprecedented accuracy, effectiveness and safety. Every year, more than 400'000 stroke treatments are carried out, and the patient's vascular system is used as an access route to deliver a treatment in the brain. However, current interventional devices do not provide sufficient control to the surgeon resulting in increased risk of complications, increased costs and increased surgery duration.
Guillaume Petit-Pierre about Verve Ventures
Having Verve Ventures engaged in our Series A funding round built trust and was decisive to attract new valuable investors supporting Artiria.
Founders / Management Guillaume Petit-Pierre, Marc Boers
Sectors Health & Bio, Medical devices
Located in Borex, Vaud (HQ), EPFL Innovation Park Geneva (offices)
Co-Investors 4FO
Follow On

LinkedIn

Sign up to receive our weekly newsletter and learn about investing in technologies that are changing the world.